Literature DB >> 9087406

A common precursor for primitive erythropoiesis and definitive haematopoiesis.

M Kennedy1, M Firpo, K Choi, C Wall, S Robertson, N Kabrun, G Keller.   

Abstract

The generation of blood cells, haematopoiesis, in the mouse embryo begins with the development of primitive nucleated erythroid cells in the yolk sac followed by the appearance of precursors for multiple definitive haematopoietic lineages. The later developing lineages arise from multipotential stem cells, but the relationship of primitive erythroid cells to these other haematopoietic populations is unknown. Using an in vitro embryonic stem (ES) cell differentiation system, we show that primitive erythrocytes and other haematopoietic lineages arise from a common multipotential precursor that develops within embryoid bodies generated from differentiated ES cells. In response to vascular endothelial growth factor and c-kit ligand these precursors give rise to colonies containing immature cells (blasts) expressing marker genes characteristic of haematopoietic precursors. Many blast colonies also expressed betaH1 and beta major globins but not Brachyury, a mesodermal marker. Kinetic analysis demonstrated that the blast colony-forming cells represent a transient population, preceding the establishment of the primitive erythroid and other lineage-restricted precursors. This precursor population may represent the earliest stage of embryonic haematopoietic commitment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9087406     DOI: 10.1038/386488a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  123 in total

Review 1.  Development of hematopoietic cells from embryonic stem cells.

Authors:  A Suzuki; T Nakano
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

2.  SCL/tal-1-dependent process determines a competence to select the definitive hematopoietic lineage prior to endothelial differentiation.

Authors:  Mitsuhiro Endoh; Minetaro Ogawa; Stuart Orkin; Shin-ichi Nishikawa
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

Review 3.  Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function.

Authors:  Silviu Itescu; Alfred A Kocher; Michael D Schuster
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 4.  Stem cells and regenerative medicine.

Authors:  Hisamaru Hirai
Journal:  Hum Cell       Date:  2002-12       Impact factor: 4.174

5.  ER71 directs mesodermal fate decisions during embryogenesis.

Authors:  Tara L Rasmussen; Junghun Kweon; Mackenzie A Diekmann; Fikru Belema-Bedada; Qingfeng Song; Kathy Bowlin; Xiaozhong Shi; Anwarul Ferdous; Tongbin Li; Michael Kyba; Joseph M Metzger; Naoko Koyano-Nakagawa; Daniel J Garry
Journal:  Development       Date:  2011-11       Impact factor: 6.868

6.  Effect of endoglin overexpression during embryoid body development.

Authors:  June Baik; Luciene Borges; Alessandro Magli; Tayaramma Thatava; Rita C R Perlingeiro
Journal:  Exp Hematol       Date:  2012-06-19       Impact factor: 3.084

7.  CD41 and CD45 expression marks the angioformative initiation of neovascularisation in human haemangioblastoma.

Authors:  Dexuan Ma; Ying Wang; Guhong Du; Jingyun Yang; Qisheng Tang; Liangfu Zhou
Journal:  Tumour Biol       Date:  2015-10-14

Review 8.  Modeling human hematopoietic stem cell biology in the mouse.

Authors:  Stephen M Sykes; David T Scadden
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

9.  Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells.

Authors:  Petter S Woll; Julie K Morris; Matt S Painschab; Rebecca K Marcus; Aimee D Kohn; Travis L Biechele; Randall T Moon; Dan S Kaufman
Journal:  Blood       Date:  2007-09-17       Impact factor: 22.113

Review 10.  Erythro-myeloid progenitors: "definitive" hematopoiesis in the conceptus prior to the emergence of hematopoietic stem cells.

Authors:  Jenna M Frame; Kathleen E McGrath; James Palis
Journal:  Blood Cells Mol Dis       Date:  2013-10-02       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.